Questions Surface In Response To FDA's Draft Guidance On Device Animal Studies
This article was originally published in The Gray Sheet
Executive Summary
Industry and regulatory groups say FDA should make it clearer in a final guidance whether it intends to only address animal studies assessing safety or if it is also targeting performance studies in a draft guidance from October. There are also questions about reporting of raw data from animal studies, and PETA weighs in.